{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:53:07Z","timestamp":1790751187283,"version":"4.1.0"},"publisher-location":"Boston, MA","reference-count":77,"publisher":"Springer New York","isbn-type":[{"value":"9781468459548","type":"print"},{"value":"9781468459524","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1991]]},"DOI":"10.1007\/978-1-4684-5952-4_39","type":"book-chapter","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T08:47:02Z","timestamp":1340786822000},"page":"425-435","source":"Crossref","is-referenced-by-count":128,"title":["Implications of Interferon-Induced Tryptophan Catabolism in Cancer, Autoimmune Diseases and Aids"],"prefix":"10.1007","author":[{"given":"R. R.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. P.","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. C.","family":"Borden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. M.","family":"Sondel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. G.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"39_CR1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1515\/9783110854657-044","volume-title":"Progress in Tryptophan and Serotonin Research 1986","author":"DA Bender","year":"1987","unstructured":"Bender, D.A., 1987, The relative importance of dietary tryptophan and preformed nicotinic acid and nicotinamide as precursors of nicotinamide nucleotide coenzymes, in: \u201cProgress in Tryptophan and Serotonin Research 1986\u201d, Bender, D.A., Joseph, M.H., Kochen, W., and Steinhart, H.W., eds., de Gruyter, Berlin, pp. 159\u2013164."},{"key":"39_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1126\/science.3122324","volume":"239","author":"EW Bernton","year":"1988","unstructured":"Bernton, E.W., Meltzer, M.S., and Holaday, J.W., 1988, Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice, Science, 239: 401\u2013404.","journal-title":"Science"},{"key":"39_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0002-9343(88)90575-X","volume":"85","author":"B Beutler","year":"1988","unstructured":"Beutler, B., 1988, The presence of cacheetin\/tumor necrosis factor in human disease states, Am. J. Med., 85: 287\u2013288.","journal-title":"Am. J. Med"},{"key":"39_CR4","first-page":"230","volume":"10C","author":"RR Brown","year":"1986","unstructured":"Brown, R.R., Borden, E.C., Sondel, P.M., Byrne, G.I., Lee, C.M., Nunnink, J.C., Schiller, J.H., and Lehman, L.K., 1986, Effects of interferons and interleukin-2 on tryptophan metabolism in humans, J. Cell Biochem. Suppl., 10C: 230.","journal-title":"J. Cell Biochem. Suppl"},{"key":"39_CR5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1515\/9783110854657-008","volume-title":"Progress in Tryptophan and Serotonin Research 1986","author":"RR Brown","year":"1987","unstructured":"Brown, R.R., Borden, E.C., Sondel, P.M., and Lee, C.M., 1987, Effects of interferons and interleukin-2 on tryptophan metabolism in humans, in: \u201cProgress in Tryptophan and Serotonin Research 1986\u201d, Bender, D.A., Joseph, M.H., Kochen, W., and Steinhart, H.W., eds., de Gruyter, Berlin, pp. 19\u201326."},{"key":"39_CR6","first-page":"4941","volume":"49","author":"RR Brown","year":"1989","unstructured":"Brown, R.R., Lee, C.M., Kohler, P.C., Hank, J.A., Storer, B.E., and Sondel, P.M., 1989, Altered tryptophan metabolism in cancer patients treated with recombinant interleukin-2, Cancer Res., 49: 4941\u20134944.","journal-title":"Cancer Res"},{"key":"39_CR7","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1002\/1097-0142(19860601)57:11<2190::AID-CNCR2820571118>3.0.CO;2-Y","volume":"57","author":"RL Burkes","year":"1986","unstructured":"Burkes, R.L., Sherrod, A.E., Stewart, M.L., Gill, P.S., Aguilar, S., Taylor, C.R., Krailo, M.D., and Levine, A.M., 1986, Serum beta-2 microglobulin levels in homosexual men with AIDS and with persistent, generalized lymphadenopathy, Cancer, 57: 2190\u20132192.","journal-title":"Cancer"},{"key":"39_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/jir.1986.6.389","volume":"6","author":"GI Byrne","year":"1986","unstructured":"Byrne, G.I., Lehmann, L.K., Kirschbaum, J.G., Borden, E.C., Lee, C.M., and Brown, R.R., 1986b, Induction of tryptophan degradation in vitro and in vivo: a gamma interferon-stimulated activity, J. Interferon Res., 6: 389\u2013396.","journal-title":"J. Interferon Res"},{"key":"39_CR9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1128\/IAI.53.2.347-351.1986","volume":"53","author":"GI Byrne","year":"1986","unstructured":"Byrne, G.I., Lehmann, L.K., and Landry, G.J., 1986a, Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells, Infect. Immun., 53: 344\u2013351.","journal-title":"Infect. Immun"},{"key":"39_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/jir.1989.9.167","volume":"9","author":"JM Carlin","year":"1989","unstructured":"Carlin J.M., Borden, E.C., and Byrne, G.I., 1989b, Enhancement of indoleamine 2,3-dioxygenase activity in cancer patients receiving interferon-\u03b2ser, J. Interferon Res., 9: 167\u2013173.","journal-title":"J. Interferon Res"},{"key":"39_CR11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jlb.45.1.29","volume":"45","author":"JM Carlin","year":"1989","unstructured":"Carlin, J.M., Borden, E.C., Sondel, P.M., and Byrne, G.I., 1989a, Interferoninduced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes, J. Leukocyte Biol., 45: 29\u201334.","journal-title":"J. Leukocyte Biol"},{"key":"39_CR12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/BF01990503","volume":"45","author":"JM Carlin","year":"1989","unstructured":"Carlin, J.M., Ozaki, Y., Byrne, G.I., Brown, R.R., and Borden, E.C., 1989c, Interferons and indoleamine 2, 3-dioxygenase: role in antimicrobial and antitumor effects, Experientia, 45: 535\u2013541.","journal-title":"Experientia"},{"key":"39_CR13","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.4049\/jimmunol.141.10.3349","volume":"141","author":"MG Cleveland","year":"1988","unstructured":"Cleveland, M.G., Annable, C.R., and Klimpel, G.R., 1988, In vivo and in vitro production of IFN-\u03b2 and IFN-\u03b3 during graft vs. host disease, J. Immunol., 141: 3349\u20133356.","journal-title":"J. Immunol"},{"key":"39_CR14","first-page":"338","volume":"28","author":"SP Datta","year":"1987","unstructured":"Datta, S.P., Brown, R.R., Borden, E.C., Sondel, P.M., and Trump, D.L., 1987a, Interferon and interleukin-2 induced changes in tryptophan and neopterin metabolism: possible markers for biologically effective doses, Proc. Am. Assoc. Cancer Res., 28: 338.","journal-title":"Proc. Am. Assoc. Cancer Res"},{"key":"39_CR15","unstructured":"Datta, S.P., Brown, R.R., Schiller, J.H., Storer, B.E., and Borden, E.C., 1987b, Neopterin (NP) levels in cancer patients treated with human recombinant interferon (IFN). Abstract, Annual Meeting of the International Soc. for Interferon Research, Washington, D.C, November 2\u20136."},{"key":"39_CR16","first-page":"346","volume":"48","author":"LM la Maza de","year":"1988","unstructured":"de la Maza, L.M., and Peterson, E.M., 1988, Dependence on the in vitro antiproliferative activity of recombinant human g-interferon on the concentration of tryptophan in culture media, Cancer Res., 48: 346\u2013350.","journal-title":"Cancer Res"},{"key":"39_CR17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-107-2-293","volume":"107","author":"KD Denicoff","year":"1987","unstructured":"Denicoff, K.D., Rubinow, D.R., Papa, M.Z., Simpson, C., Seipp, C.A., Lotze, M.T., Chang, A.E., Rosenstein, D., and Rosenberg, S.A., 1987, The neuropsychiatrie effects of treatment with interleukin-2 and lymphokine-activated killer cells, Ann. Internal. Med., 107: 293\u2013300.","journal-title":"Ann. Internal. Med"},{"key":"39_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/infdis\/146.4.451","volume":"146","author":"E DeStefano","year":"1982","unstructured":"DeStefano, E., Friedman, R.M., Friedman-Kien, A.E., et al., 1982, Acid-labile human leukocyte interferon in homosexual men with Kaposi\u2019s sarcoma and lymphadenopathy, J. Infect. Dis., 146: 451\u2013455.","journal-title":"J. Infect. Dis"},{"key":"39_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJM198309083091003","volume":"309","author":"ME Eyster","year":"1983","unstructured":"Eyster, M.E., Goedert, J.J., Poon, M-C., and Preble, O.T., 1983, Acid-labile alpha interferon. A possible preclinical marker for the acquired immunodeficiency syndrome in hemophilia, N. Engl. J. Med., 309: 583\u2013586.","journal-title":"N. Engl. J. Med"},{"key":"39_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1159\/000122753","volume":"25","author":"C Ferrari","year":"1978","unstructured":"Ferrari, C., Caldara, R., Romussi, M., Rampini, P., Telloli, P., Zaatar, S., and Curtarelli, G., 1978, Prolactin suppression by serotonin antagonists in man: further evidence for serotoninergic control of prolactin secretion, Neuroendocrinology, 25: 319\u2013328.","journal-title":"Neuroendocrinology"},{"key":"39_CR21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1089\/jir.1988.8.705","volume":"8","author":"LME Finocchiaro","year":"1988","unstructured":"Finocchiaro, L.M.E., Arzt, E.S., Fernandez-Castelo, S., Criscuolo, M., Finkielman, S., and Nahmod, V.E., 1988, Serotonin and melatonin synthesis in peripheral blood mononuclear cells: stimulation by interferon-gamma as part of an immunomodulatory pathway, J. Interferon Res., 8: 705\u2013716.","journal-title":"J. Interferon Res"},{"key":"39_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/art.1780070303","volume":"7","author":"JH Flinn","year":"1964","unstructured":"Flinn, J.H., Price, J.M., Yess, N., and Brown, R.R., 1964, Excretion of tryptophan metabolites by patients with rheumatoid arthritis, Arthr. Rheumatol., 7: 201\u2013210.","journal-title":"Arthr. Rheumatol"},{"key":"39_CR23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/bmj.297.6645.422-c","volume":"297","author":"D Fuchs","year":"1988","unstructured":"Fuchs, D., and Wachter, H., 1988, Inflammatory joint disease and HIV infection, Brit. Med. J., 297: 422\u2013423.","journal-title":"Brit. Med. J"},{"key":"39_CR24","first-page":"319","volume-title":"Biochemical and Clinical Aspects of Pteridines","author":"FD Goebel","year":"1985","unstructured":"Goebel, F.D., Erfle, V., Piechowiak, H., Hien, P., Schloz, R., and Hehlmann, R., 1985, The relations of HTLV-III antibodies to neopterin and beta-2-microglobulin in the serum of patients with AIDS or persons at risk, in: \u201cBiochemical and Clinical Aspects of Pteridines\u201d, Vol. 4, Wachter, H., Curtius, H.C., and Pfleiderer, W., eds., de Gruyter, Berlin, pp. 319\u2013333."},{"key":"39_CR25","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/jnci\/81.14.1061","volume":"81","author":"D Goldstein","year":"1989","unstructured":"Goldstein, D., Sielaff, K.M., Storer, B.E., Brown, R.R., Datta, S.P., Witt, P.L., Teitelbaum, A.P., Smalley, R.V., and Borden, E.C., 1989, Human biological response modification by interferon in the absence of measurable serum concentrations: a comparative trial of subcutaneous and intravenous interferon-\u03b2ser, J. Nat. Cancer Inst., 81: 1061\u20131068.","journal-title":"J. Nat. Cancer Inst"},{"key":"39_CR26","doi-asserted-by":"crossref","first-page":"828","DOI":"10.7326\/0003-4819-107-6-828","volume":"107","author":"I Grant","year":"1987","unstructured":"Grant, I., Atkinson, J.H., Hesselink, J.R., Kennedy, C.J., Richman, D.D., Spector, S.A., and McCutchan, J.A., 1987, Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections, Ann. Int. Med., 107: 828\u2013836.","journal-title":"Ann. Int. Med"},{"key":"39_CR27","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1056\/NEJM198404053101413","volume":"310","author":"JA Green","year":"1984","unstructured":"Green, J.A., and Spruance, S.L., 1984, Acid-labile alpha interferon, New Engl. J. Med., 310: 922\u2013923.","journal-title":"New Engl. J. Med"},{"key":"39_CR28","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/000348946907800216","volume":"78","author":"P Hansotia","year":"1969","unstructured":"Hansotia, P., Peters, H., Bennet, M., and Brown, R.R., 1969, Chelation therapy in Wegner\u2019s granulomatosis treatment with EDTA, Ann. Otol. Rhinol. Laryngol., 78: 388\u2013402.","journal-title":"Ann. Otol. Rhinol. Laryngol"},{"key":"39_CR29","first-page":"532","volume":"369","author":"H Hasegawa","year":"1988","unstructured":"Hasegawa, H., Kobayashi, T., and Ichiyama, A., 1988, 2,4-Diamino-6-hydroxypyrimidine (DAHP) induces intestinal disorder in mice: an animal model of serotonin deficiency by inhibition of tetrahydrobiopterin (THBP) synthesis, Biol. Chem. Hoppe-Seyler, 369: 532.","journal-title":"Biol. Chem. Hoppe-Seyler"},{"key":"39_CR30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/9783111641546-005","volume-title":"Progress in Tryptophan and Serotonin Research","author":"O Hayaishi","year":"1984","unstructured":"Hayaishi, O., Yoshida, R., Takikawa, O., Yasui, H., 1984, Indoleamine dioxygenase \u2014 a possible biological function, in: \u201cProgress in Tryptophan and Serotonin Research\u201d, Schlossberger, H.G., Kochen, W., Linzen, B., and Steinhart, H., eds., de Gruyter, Berlin, pp. 33\u201342."},{"key":"39_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/ana.410260215","volume":"26","author":"MP Heyes","year":"1989","unstructured":"Heyes, M.P., Rubinow, D., Lane, C., and Markey, S.P., 1989, Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome, Ann. Neurol., 26: 275\u2013277.","journal-title":"Ann. Neurol"},{"key":"39_CR32","first-page":"582","volume":"17","author":"C Huber","year":"1985","unstructured":"Huber, C., Troppmair, J., Fuchs, D., Hausen, A., Lang, D., Niederwieser, D., Reibnegger, G., Swetly, P., Wachter, H., and Margreiter, R., 1985, Immune response-associated production of neopterin-release from macrophages under control of lymphokines, Transplant Proc., 17: 582\u2013585.","journal-title":"Transplant Proc"},{"key":"39_CR33","first-page":"505","volume":"54","author":"JC Jackson","year":"1985","unstructured":"Jackson, J.C., Cross, R.J., Walker, R.F., Markesberry, W.R., Brooks, W.H., and Roszman, T.L., 1985, Influence of serotonin on the immune response, Immunology, 54: 505\u2013512.","journal-title":"Immunology"},{"key":"39_CR34","first-page":"2556","volume":"45","author":"ML Karnovsky","year":"1986","unstructured":"Karnovsky, M.L., 1986, Muramyl peptides in mammalian tissues and their effects at the cellular level, Fed. Proc, 45: 2556\u20132560.","journal-title":"Fed. Proc"},{"key":"39_CR35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.2437656","volume":"236","author":"FC Kull Jr.","year":"1987","unstructured":"Kull, F.C., Jr., Brent, D.A., Parikh, I., and Cuatrecasas, P., 1987, Chemical identification of a tumor-derived angiogenic factor, Science, 236: 843\u2013845.","journal-title":"Science"},{"key":"39_CR36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0002-9343(88)90576-1","volume":"85","author":"J Lahdevirta","year":"1988","unstructured":"Lahdevirta, J., Maury, C.P.J., Teppo, A-M., and Repo, H., 1988, Elevated levels of circulating cachetin\/tumor necrosis factor in patients with acquired immunodeficiency syndrome, Am. J. Med., 85: 289\u2013291.","journal-title":"Am. J. Med"},{"key":"39_CR37","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/jnr.490230410","volume":"23","author":"M Larsson","year":"1989","unstructured":"Larsson, M., Hagberg, L., Norkrans, G., and Forsman, A., 1989, Indoleamine deficiency in blood and cerebrospinal fluid from patients with human immunodeficiency virus infection, J. Neurosci. Res., 23: 441\u2013446.","journal-title":"J. Neurosci. Res"},{"key":"39_CR38","first-page":"324","volume":"1","author":"J-M Launay","year":"1988","unstructured":"Launay, J-M., Copel, L., Callebert, J., Corvaia, N., Lepage, E., Bricare, F., Saal, F., and Peries, J., 1988, Decreased whole blood 5-hydroxytryptamine (serotonin) in AIDS patients, J. Acquired Immune Defic. Synd., 1: 324\u2013325.","journal-title":"J. Acquired Immune Defic. Synd"},{"key":"39_CR39","unstructured":"Laurence, J., 1987, Dermatologic manifestations of HIV infection, Infections in Med., Jul\/Aug, 241\u2013251."},{"key":"39_CR40","first-page":"A822","volume":"3","author":"MA Leyko","year":"1989","unstructured":"Leyko, M.A., and Varesio, L., 1989, Role for tryptophan and its metabolites in the activation of macrophage tumor cytotoxicity, FASEB J., 3: A822.","journal-title":"FASEB J"},{"key":"39_CR41","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1016\/0006-2952(82)90577-9","volume":"31","author":"P Lloyd","year":"1983","unstructured":"Lloyd, P., Stribling, D., and Pogson, C.I., 1983, Endotoxin and tryptophaninduced hypoglycaemia in rats, Biochem. Pharmacol., 31: 3571\u20133576.","journal-title":"Biochem. Pharmacol"},{"key":"39_CR42","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1172\/JCI107381","volume":"52","author":"JH Maclndoe","year":"1973","unstructured":"Maclndoe, J.H., and Turkington, R.W., 1973, Stimulation of human prolactin secretion by intravenous infusion of L-tryptophan, J. Clin. Invest., 52: 1972\u20131978.","journal-title":"J. Clin. Invest"},{"key":"39_CR43","first-page":"4250","volume":"48","author":"T Manda","year":"1988","unstructured":"Manda, T., Nishigaki, F., Mor, J., and Shimomura, K., 1988, Important role of serotonin in the antitumor effects of recombinant tumor necrosis factor-a in mice, Cancer Res., 48: 4250\u20134255.","journal-title":"Cancer Res"},{"key":"39_CR44","first-page":"1175","volume":"2","author":"EM McDonald","year":"1978","unstructured":"McDonald, E.M., Mann, A.H., and Thomas, H.C., 1978, Interferons as mediators of psychiatric morbidity, Lancet, 2: 1175\u20131178.","journal-title":"Lancet"},{"key":"39_CR45","first-page":"70","volume":"2","author":"RN Melmed","year":"1989","unstructured":"Melmed, R.N., Taylor, J.M.G., Detels, R., Bozorgmehri, M., and Fahey, J.L., 1989, Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS, J. Acquired Immune Defic, 2: 70\u201376.","journal-title":"J. Acquired Immune Defic"},{"key":"39_CR46","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1136\/jnnp.42.7.640","volume":"42","author":"F Monaco","year":"1979","unstructured":"Monaco, F., Fumero, S., Mondino, A., and Mutani, R., 1979, Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative disdiseases, J. Neurol. Neurosurg. Psych., 42: 640\u2013641.","journal-title":"J. Neurol. Neurosurg. Psych"},{"key":"39_CR47","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/0304-4165(71)90221-2","volume":"230","author":"RJ Moon","year":"1971","unstructured":"Moon, R.J., 1971, Tryptophan oxygenase and tryptophan metabolism in endotoxin-poisoned and allopurinol-treated mice, Biochim. Biophys. Acta, 230: 324\u2013348.","journal-title":"Biochim. Biophys. Acta"},{"key":"39_CR48","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1111\/j.1471-4159.1986.tb13071.x","volume":"47","author":"F Moroni","year":"1986","unstructured":"Moroni, F., Lombardi, G., Carla, V., Lai, S., Etienne, P., and Nair, N.P.V., 1986, Increase in the content of quinolinic acid in cerebrospinal fluid and frontal cortex of patients with hepatic failure, J. Neurochem., 47: 1667\u20131671.","journal-title":"J. Neurochem"},{"key":"39_CR49","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1056\/NEJM198805123181923","volume":"318","author":"HW Murray","year":"1988","unstructured":"Murray, H.W., DePamphilis, J., Schooley, R.T., and Hirsch, M.S., 1988, Circulating interferon gamma in AIDS patients treated with interleukin-2, New Engl. J. Med., 318: 1538\u20131539.","journal-title":"New Engl. J. Med"},{"key":"39_CR50","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ana.410190603","volume":"19","author":"BA Navia","year":"1986","unstructured":"Navia, B.A., Cho, E-S., Petito, C.K., and Price, R.W., 1986, The AIDS dementia complex: II. Neuropathology, Ann. Neurol., 19: 525\u2013535.","journal-title":"Ann. Neurol"},{"key":"39_CR51","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/0006-291X(87)91431-8","volume":"144","author":"Y Ozaki","year":"1987","unstructured":"Ozaki, Y., Edelstein, M.P., and Duch, D.S., 1987, The action of interferon and antiinflammatory agents on induction of indoleamine 2, 3-dioxygenase in human peripheral blood monocytes, Biochem. Biophys. Res. Commun., 144: 1147\u20131153.","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"39_CR52","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1073\/pnas.85.4.1242","volume":"85","author":"Y Ozaki","year":"1988","unstructured":"Ozaki, Y., Edelstein, M.P., and Duch, D.S., 1988, Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferongamma, Proc. Natl. Acad. Sci. USA, 85: 1242\u20131246.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"39_CR53","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1073\/pnas.81.3.908","volume":"81","author":"ER Pfefferkorn","year":"1984","unstructured":"Pfefferkorn, E.R., 1984, Interferon-gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan, Proc. Natl. Acad. Sci. USA, 81: 908\u2013912.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"39_CR54","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0166-6851(86)90101-5","volume":"20","author":"ER Pfefferkorn","year":"1986","unstructured":"Pfefferkorn, E.R., Eckel, M., and Rebhun, S., 1986, Interferon-gamma suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan, Mol. Biochem. Parasitol., 20: 215\u2013224.","journal-title":"Mol. Biochem. Parasitol"},{"key":"39_CR55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/jid.1957.102","volume":"29","author":"JM Price","year":"1957","unstructured":"Price, J.M., Brown, R.R., Rukavina, J.G., Mendelson, C., and Johnson, S.A.M., 1957, Scleroderma (Acrosclerosis). II. Tryptophan metabolism before and during treatment by chelation (EDTA), J. Invest. Dermatol., 29: 289\u2013298.","journal-title":"J. Invest. Dermatol"},{"key":"39_CR56","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/ajcn\/24.7.807","volume":"24","author":"MI Rapoport","year":"1971","unstructured":"Rapoport, M.I., and Beisel, W.R., 1971, Studies of tryptophan metabolism in experimental animals and man during infectious illness, Am. J. Clin. Nutr., 24: 807\u2013814.","journal-title":"Am. J. Clin. Nutr"},{"key":"39_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0171-2985(86)80084-5","volume":"173","author":"G Reibnegger","year":"1986","unstructured":"Reibnegger, G., Bollbach, R., Fuchs, D., Hausen, A., Judmaier, G., Prior, C., Rotthauwe, H.W., Werner, E.R., and Wachter, H., 1986, A simple index relating clinical activity in Crohn\u2019s disease with T cell activation: hematocrit, frequency of liquid stools and urinary neopterin as parameters, Imnmnobiology, 173: 1\u201311.","journal-title":"Imnmnobiology"},{"key":"39_CR58","first-page":"1045","volume":"63","author":"J Roberts","year":"1979","unstructured":"Roberts, J., Schmid, F.A., and Rosenfeld, H.J., 1979, Biologic and antineoplastic effects of enzyme-mediated in vivo depletion of L-glutamine, L-tryptophan, and L-histidine, Cancer Treatment Rep., 63: 1045\u20131054.","journal-title":"Cancer Treatment Rep"},{"key":"39_CR59","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1210\/endo-105-1-163","volume":"105","author":"S Spampinato","year":"1979","unstructured":"Spampinato, S., Locatelli, V., Cocchi, D., Vicentini, L., Bajusz, S., Ferri, S., and M\u00fcller, E.E., 1979, Involvement of brain serotonin in the prolactin-releasing effect of opioid peptides, Endocrinology, 105: 163\u2013170.","journal-title":"Endocrinology"},{"key":"39_CR60","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4049\/jimmunol.137.1.276","volume":"137","author":"EM Sternberg","year":"1986","unstructured":"Sternberg, E.M., Trial, J., and Parker, C.W., 1986, Effect of serotonin on murine macrophages: suppression of Ia expression by serotonin and its reversal by 5-HT2 serotonergic receptor antagonists, J. Immunol., 137: 276\u2013282.","journal-title":"J. Immunol"},{"key":"39_CR61","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1056\/NEJM198010023031403","volume":"303","author":"EM Sternberg","year":"1980","unstructured":"Sternberg, E.M., Van Woert, M.H., Young, S.N., Magnussen, I., Baker, H., Gauthier, S., and Osterland, C.K., 1980, Development of a sclerodermalike illness during therapy with L-5-hydroxytryptophan and carbidopa, New Engl. J. Med., 303: 782\u2013787.","journal-title":"New Engl. J. Med"},{"key":"39_CR62","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0021-9258(19)77982-4","volume":"263","author":"O Takikawa","year":"1988","unstructured":"Takikawa, O., Kuroiwa, T., Yamazaki, F., and Kido, R., 1988, Mechanism of interferon-gamma action; characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity, J. Biol. Chem., 263: 2041\u20132048.","journal-title":"J. Biol. Chem"},{"key":"39_CR63","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1016\/S0021-9258(17)35696-X","volume":"261","author":"O Takikawa","year":"1986","unstructured":"Takikawa, O., Yoshida, R., Kido, R., and Hayaishi, O., 1986, Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase, J. Biol. Chem., 261: 3648\u20133653.","journal-title":"J. Biol. Chem"},{"key":"39_CR64","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0307-742X(21)00608-1","volume":"11","author":"N Talal","year":"1985","unstructured":"Talal, N., 1985, Interleukins, interferon and rheumatic disease, Clin. Rheum. Dis., 11: 633\u2013644.","journal-title":"Clin. Rheum. Dis"},{"key":"39_CR65","first-page":"1","volume":"7","author":"PJM Tutton","year":"1987","unstructured":"Tutton, P.J.M., and Barkla, D.H., 1987, Biogenic amines as regulators of the proliferative activity of normal and neoplastic intestinal epithelial cells, Anticancer Res., 7: 1\u201312.","journal-title":"Anticancer Res"},{"key":"39_CR66","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jn\/88.1.93","volume":"88","author":"VM Vivian","year":"1966","unstructured":"Vivian, V.M., Brown, R.R., Price, J.M., and Reynolds, M.S., 1966, Some aspects of tryptophan and niacin metabolism in young women consuming a low tryptophan diet supplemented with niacin, J. Nutr., 88: 93\u201399.","journal-title":"J. Nutr"},{"key":"39_CR67","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1515\/bchm2.1983.364.2.1345","volume":"364","author":"H Wachter","year":"1983","unstructured":"Wachter, H., Fuchs, D., Hausen, A., Huber, C., Knosp, O., Reibnegger, G., and Spira, T., 1983, Elevated urinary neopterin levels in patient\u2019s with the acquired immunodeficiency syndrome (AIDS), Hoppe Seyler\u2019s Z. Physiol. Chem., 364: 1345\u20131346.","journal-title":"Hoppe Seyler\u2019s Z. Physiol. Chem"},{"key":"39_CR68","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0024-3205(87)90149-4","volume":"41","author":"ER Werner","year":"1987","unstructured":"Werner, E.R., Bitterlich, G., Fuchs, D., Hausen, A., Reibnegger, G., Szabo, G., Dierich, M.P. and Wachter, H., 1987, Human macrophages degrade tryptophan upon induction by interferon-gamma, Life Sci., 41: 273\u2013280.","journal-title":"Life Sci"},{"key":"39_CR69","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1515\/bchm3.1988.369.1.337","volume":"369","author":"ER Werner","year":"1988","unstructured":"Werner, E.R., Fuchs, D., Hausen, A., Jaeger, H., Reibnegger, G., Werner-Felmayer, G., Dierich, M.P., and Wachter, H., 1988, Tryptophan degradation in patients infected by human immunodeficiency virus, Biol. Chem. Hoppe-Seyler, 369: 337\u2013340.","journal-title":"Biol. Chem. Hoppe-Seyler"},{"key":"39_CR70","first-page":"473","volume-title":"Biochemical and Clinical Aspects of Pteridines","author":"ER Werner","year":"1985","unstructured":"Werner, E.R., Fuchs, D., Hausen, A., Lutz, H., Reibnegger, G., and Wachter, H., 1985, Interferon-gamma-induced in vitro-excretion of neopterin and 3-hydroxyanthranilic acid by human macrophages, in: \u201cBiochemical and Clinical Aspects of Pteridines\u201d, Vol. 4, Wachter, H., Curtius H.C., and Pfleiderer, W., eds., de Gruyter, Berlin, pp. 473\u2013406."},{"key":"39_CR71","first-page":"1010","volume":"34","author":"PV Wooley III","year":"1974","unstructured":"Wooley, P.V., III, Dion, R.L. and Bono, V.H., Jr., 1974, Effects of tryptophan deprivation on L1210 cells in culture, Cancer Res., 34: 1010\u20131014.","journal-title":"Cancer Res"},{"key":"39_CR72","doi-asserted-by":"publisher","first-page":"6622","DOI":"10.1073\/pnas.83.17.6622","volume":"83","author":"H Yasui","year":"1986","unstructured":"Yasui, H., Takai, K., Yoshida, Y., and Hayaishi, O., 1986, Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: its possible occurrence in cancer patients, Proc. Natl. Acad. Sci. USA, 83: 6622\u20136626.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"39_CR73","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1073\/pnas.75.8.3998","volume":"75","author":"R Yoshida","year":"1978","unstructured":"Yoshida, R., and Hayaishi, O., 1978, Induction of pulmonary indo1eamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide, Proc. Natl. Acad. Sci. USA, 75: 3998\u20134001.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"39_CR74","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1073\/pnas.78.1.129","volume":"78","author":"R Yoshida","year":"1981","unstructured":"Yoshida, R., Imanishi, J., Oku, T., Kishida, T., and Hayaishi, O., 1981, Induction of pulmonary indoleamine 2,3-dioxygenase by interferon, Proc. Natl. Acad. Sci. USA, 78: 129\u2013132.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"39_CR75","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.4049\/jimmunol.141.8.2819","volume":"141","author":"R Yoshida","year":"1988","unstructured":"Yoshida, R., Park, S.W., Yasui, H., and Hayaishi, O., 1988, Tryptophan degradation in transplanted tumor cells undergoing rejection, J. Immunol., 141: 2819\u20132823.","journal-title":"J. Immunol"},{"key":"39_CR76","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1073\/pnas.76.8.4084","volume":"76","author":"R Yoshida","year":"1979","unstructured":"Yoshida, R., Urade, M., Tokuda, M., and Hayaishi, O., 1979, Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection, Proc. Natl. Acad. Sci. USA, 76: 4084\u20134088.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"39_CR77","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1001\/jama.1984.03340460029020","volume":"251","author":"S Zolla-Pazner","year":"1984","unstructured":"Zolla-Pazner, S., William, D., El-Sadr, W., Marmor, M., and Stahl, R., 1984, Quantitation of \u03b2-2-microglobulin and other immune characteristics in a prospective study of men at risk for acquired immune deficiency syndrome, J. Am. Med. Assoc., 251: 2951\u20132955.","journal-title":"J. Am. Med. Assoc"}],"container-title":["Advances in Experimental Medicine and Biology","Kynurenine and Serotonin Pathways"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4684-5952-4_39.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T22:32:44Z","timestamp":1687559564000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4684-5952-4_39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991]]},"ISBN":["9781468459548","9781468459524"],"references-count":77,"URL":"https:\/\/doi.org\/10.1007\/978-1-4684-5952-4_39","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[1991]]}}}